Federal officials have announced that the clinics across the country would vaccinate individuals with presumed exposure to the monkeypox virus. Earlier, the U.S. had reserved the vaccine for individuals who had confirmed exposure to the virus. The U.S. has confirmed a preference for the Jynneos vaccine from Bavarian Nordic A/S (OMX:BAVA). In May, Bavarian Nordic entered…